Lung Cancer Trial, Recruiting NCT06304441 Sponsor: Guangzhou Medical University Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Recruiting

NCT06304441
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 75 years, either male or female
  • People who have been diagnosed with non-small cell lung cancer (a type of lung cancer), confirmed by a tissue or cell sample, with a specific type of genetic change in the EGFR gene (known as L858R or Exon19 deletion)
  • People who have been diagnosed with leptomeningeal metastasis (cancer that has spread to the fluid and membranes surrounding the brain and spinal cord), confirmed using established medical guidelines
  • People whose liver and kidney function is within normal range, and whose blood cell and platelet counts meet the required levels
  • People with no history of serious nervous system disease
  • People with no serious blood or bone marrow disorders

Who may not be able to join:

  • People showing signs of nervous system failure, such as severe brain dysfunction, significant white matter changes seen on brain scans, or a reduced level of consciousness as measured by a standard medical scale (confirm with trial site)
  • People whose cancer has spread widely throughout the body in a way that is considered life-threatening and is not responding to any treatment
  • People who may have difficulty following the study requirements, or who have other reasons that the trial team considers unsuitable for participation

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8615804302753

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Guangzhou Medical University
Registry
ClinicalTrials.gov
Start date
18 April 2024
Est. completion
20 June 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Clinical response rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov